Latest filing published 01 Jul 2020 for Arix Bioscience plc.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Marcus Karia: trading record in brief
All filings by Marcus Karia on record concern Arix Bioscience plc. In total, 2 filings cover trades dated from 16 April 2020 to 30 June 2020.
No open-market sale appears; the market trades are 1 purchase worth €11k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 option exercise.
The latest filing, published on 1 July 2020, reports an option exercise in Arix Bioscience plc. The last purchase on record was published on 17 April 2020, which is 2,396 days ago. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
Companies and markets linked to Marcus Karia
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 389,133 sharesOutside a trading venueISIN GB00BD045071FCA-NSM:202007010200PR_NEWS_UKDISCLO_0030-2
- 11,604 shares@ £0.8617London Stock Exchange (XLON)ISIN GB00BD045071FCA-NSM:202004170959PR_NEWS_UKDISCLO_0079-1Canonical exit: 15 Jul 2020 (T+90)
2 of 2 declarations